Review: Small-fiber neuropathy

Neurologist

Volumn 8, Issue 4, 2002, Pages 237-253

  Al Shekhlee, Amer ^a   Chelimsky, Thomas C ^a   Preston, David C ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Neuropathy; Pain and temperature; Small fiber

Indexed keywords

AUTONOMIC DYSFUNCTION; CLINICAL EXAMINATION; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DYSESTHESIA; ELECTROMYOGRAM; EVALUATION; GENETIC DISORDER; HUMAN; INFECTION; INFLAMMATION; METABOLIC DISORDER; NERVE CONDUCTION; NERVE FIBER; NEUROPATHY; PAIN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; SYMPTOM; TEMPERATURE;

EID: 0036322109     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00127893-200207000-00004     Document Type: Review

References (93)

1. The current neurologic burden of illness in the United States
2. Chronic symmetric symptomatic polyneuropathy in the elderly: A field screening investigation of risk factors for polyneuropathy in two Italian communities
3. Idiopathic painful sensory neuropathy
4. Small-fiber sensory neuropathies: Clinical course and neuropathology of idiopathic cases
5. Positive manifestations of nerve fiber dysfunction: Clinical, electrophysiologic, and pathologic correlates
6. Distal small fiber neuropathy
7. Chronic cryptogenic sensory polyneuropathy: Clinical and laboratory characteristics
8. Why don't we teach and treat diabetic patients better?
9. Diabetic neuropathy
10. The role of endogenous nerve growth factor in human diabetic neuropathy
11. Diabetic and hypoglycemic neuropathy
12. Painful sensory polyneuropathy associated with impaired glucose tolerance
13. The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy
14. Prevalence of diabetic autonomic neuropathy measured by simple bedside tests
15. Prolonged QT period in diabetic autonomic neuropathy: A possible role in sudden cardiac death?
16. Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients
17. Corrected Q-T interval prolongation as diagnostic tool for assessment of cardiac autonomic neuropathy in diabetes mellitus
18. Diabetic neuropathy: Scope of the syndrome
19. Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy
20. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF
21. Neuropathy associated with hyperlipidemia
22. Essential hpemia, acute gout, peripheral neuritis, and myocardial disease in a Negro man: Response to corticotropin
23. Familial amyloid polyneuropathy: Presentation, diagnosis, and treatment
24. Amyloidosis (AL). Clinical and laboratory features in 229 cases
25. The natural history of peripheral neuropathy in primary systemic amyloidosis
26. Peripheral nerve changes in amyloid neuropathy
27. A new transthyretin variant (Ser23Asn) associated with familial amyloidosis in a Portuguese patient
28. Familial amyloidosis: A study of 52 North American-born patients examined during a 30-year period
29. Peripheral nerve amyloidosis
30. Dissociated sensation in amylidosis. Compound action potential, quantitative histologic and teased-fiber, and electron microscopic studies of sural nerve biopsies
31. Relief of pain of Fabry's disease by diphenylhydantoin
32. Psychiatric disorders in patients with Fabry's disease
33. Fabry disease: Impaired autonomic function
34. Amplification of human polymorphic sites in the X-chromosomal region q21.33 to q24:DXS17, DXS87, DXS287, and alpha-galactosidase-A
35. Painful fingers, heat intolerance, and telangiectases of the ear: Easily ignored childhood signs of Fabry disease
36. Small fiber neuropathy and vasculitis
37. Extrahepatic manifestations of hepatitis C
38. Neurologic complications associated with hepatitis C virus infection
39. High incidence of hepatitis C virus infection in patients with cryoglobulinemic neuropathy
40. Peripheral neuropathy in essential mixed cryoglobulinemia
41. A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection
42. Peripheral neuropathy associated with acquired immunodeficiency syndrome. Prevalence and clinical features from a population-based survey
43. Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patients
44. The spectrum of peripheral neuropathy associated with ARC and AIDS
45. Sensory motor neuropathy associated with AIDS
46. Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex
47. Association of painful peripheral neuropathy in AIDS with cytomegalovirus infection
48. Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea
49. Low-dose zalcitabine-related toxic neuropathy: Frequency, natural history, and risk factors
50. Epstein-Barr virus-associated acute autonomic neuropathy
51. Acute autonomic and sensory neuropathy associated with elevated Epstein-Barr virus antibody titre
52. Idiopathic autonomic neuropathy: Clinical, neurophysiologic, and follow-up studies on 27 patients
53. Small-fiber dysfunction in a Borrelia burgdorferi infection
54. Temperature linked sensory loss: A unique pattern in leprosy
55. Leprosy in peripheral neuropathy
56. Polyneuropathy due to nutritional deficiency and alcoholism
57. Painful alcoholic polyneuropathy with predominant small-fiber loss and normal thiamine status
58. Metronidazole neuropathy
59. Toxic neuropathies
60. Metal neuropathy
61. Thallium poisoning in group assassination attempt
62. Initial sensorimotor and delayed autonomic neuropathy in acute thallium poisoning
63. Epidemic neuropathy in Cuba: A plea to end the United States economic embargo on a humanitarian basis
64. Cyanocobalamin (B12): Deficiency and dysautonomia
65. Vitamin B6 in clinical neurology
66. Xanthomatous neuropathy in primary biliary cirrhosis
67. Large and small fibre type sensory dysfunction in patients with cancer
68. Impaired glucose tolerance-does it cause neuropathy?
69. Quantitative sudomotor axon reflex test in normal and neuropathic subjects
70. Comparison of distal sympathetic with vagal function in diabetic neuropathy
71. Autonomic neural dysfunction in recently diagnoseddiabetic subjects
72. Distal small fiber neuropathy: Results of tests of sweating and autonomic cardiovascular reflexes
73. Testing for autonomic function
74. Clinical measures of nerve conduction
75. Quantitative sensory testing
76. Clinical neurophysiology laboratory tests to assess the nociceptive system in humans
77. Current perception thresholds: A new, quick, and reproducible method for the assessment of peripheral neuropathy in diabetes mellitus
78. Cutaneous innervation in sensory neuropathies: Evaluation by skin biopsy
79. A skin blister method to study epidermal nerves in peripheral nerve disease
80. Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies
81. Idiopathic small-fiber sensory neuropathy in childhood: A diagnosis based on objective findings on punch skin biopsy specimens
82. Painful sensory neuropathy: Prospective evaluation using skin biopsy
83. Comparison of different modalities for detection of small fiber neuropathy
84. Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation
85. Peripheral nerves regenerated in familial amyloid polyneuropathy after liver transplantation
86. Idiopathic distal small fiber neuropathy
87. Does capsaicin relieve the pain of diabetic neuropathy?
88. Treatment of painful diabetic neuropathy with topical capsaicin, a multicenter, double-blind, vehicle-controlled study
89. Double-blind, placebo-controlled study of the application of capsaicin cream in chronic distal painful polyneuropathy
90. Diabetic neuropathy: Pathogenesis and therapy
91. Diabetic neuropathy